Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, zolpidem tartrate (Edluar®) cannot be endorsed for use within NHS Wales for the short term treatment of insomnia. |
||
|
||
Medicine details |
||
| Medicine name | zolpidem tartrate (Edluar®) | |
| Formulation | 5 mg sublingual tablet | |
| Reference number | 1942 | |
| Indication | For the short term treatment of insomnia. |
|
| Company | Meda Pharmaceuticals Ltd | |
| BNF chapter | Central nervous system | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Ratification by Welsh Government | 16/01/2013 | |
| Date of issue | 23/01/2013 | |